Profile picture

Associate Professor Michael Blazing

Duke Clinical Research Institute, Durham (United States of America)
Follow
Logo ESC

Contributor content

Comparative efficacy of ezetimibe plus simvastatin combined therapy vs. simvastatin monotherapy for individuals with reduced estimated glomerular filtration rate
Presentation
Comparative efficacy of ezetimibe plus simvastatin combined therapy vs. simvastatin monotherapy for individuals with reduced estimated glomerular filtration rate

ESC 365 is supported by